PubRank

J J Crowley

Author PubWeight™ 98.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999 11.44
2 Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991 3.01
3 Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995 2.89
4 Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax 1992 2.11
5 Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 1998 1.91
6 Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 1990 1.57
7 Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest 1995 1.56
8 Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study. J Clin Oncol 1994 1.49
9 Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study. Br J Dermatol 2012 1.42
10 Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996 1.41
11 Intra-arterial thrombolysis (reteplase) and ReoPro for subacute thrombosis of the distal aorta accomplished by radial arterial access: the radial-kissing-thrombolytic technique. Catheter Cardiovasc Interv 2001 1.39
12 Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group. Cancer 1997 1.38
13 Phase II clinical trial design for noncytotoxic anticancer agents for which time to disease progression is the primary endpoint. Control Clin Trials 2000 1.33
14 Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation 1975 1.22
15 A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg 1993 1.19
16 Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team. J Thorac Cardiovasc Surg 2000 1.15
17 Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001 1.14
18 The management of ovarian-cancer-caused bowel obstruction. Gynecol Oncol 1981 1.14
19 Synchronous multicentric osteosarcoma: the case for metastases. Skeletal Radiol 1997 1.11
20 PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. Immunopharmacology 1999 1.10
21 Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis. Br J Dermatol 2011 1.06
22 Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control 2001 1.04
23 Residual intake and body weight gain: a new measure of efficiency in growing cattle. J Anim Sci 2011 1.01
24 A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial. J Nutr Health Aging 2013 1.00
25 Deep resequencing and association analysis of schizophrenia candidate genes. Mol Psychiatry 2012 1.00
26 Long-term, low-level microwave irradiation of rats. Bioelectromagnetics 1992 1.00
27 Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). Blood 2001 0.99
28 Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study. Ann Oncol 2005 0.99
29 High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial. J Clin Oncol 1999 0.98
30 Characterization of four homologous L chain variable region genes that are related to 6B6.6 idiotype positive human rheumatoid factor L chains. J Immunol 1989 0.98
31 Solitary brain metastasis: results of an RTOG/SWOG protocol evaluation surgery + RT versus RT alone. Am J Clin Oncol 1990 0.97
32 Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study. J Clin Oncol 1987 0.97
33 Acute coronary embolism complicating aortic valve endocarditis treated with streptokinase and aspirin. A case report. J Heart Valve Dis 1994 0.96
34 Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study. Invest New Drugs 1990 0.95
35 A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study. Cancer 1995 0.93
36 Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial. J Thorac Cardiovasc Surg 1993 0.93
37 Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. Transplantation 1983 0.90
38 Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group Study. J Clin Oncol 1998 0.89
39 Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. J Clin Oncol 1990 0.89
40 Acute hemodynamic changes during carotid artery stenting. Am J Cardiol 1998 0.89
41 Independent lung ventilation with a single ventilator using a variable resistance valve. Chest 1995 0.89
42 Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group study. J Clin Oncol 1998 0.89
43 Hazardous substances, the environment and public health: a statistical overview. Environ Health Perspect 1979 0.88
44 Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3',5'-adenosine monophosphate. Am Rev Respir Dis 1988 0.87
45 Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience. Chest 1991 0.87
46 Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer. J Clin Oncol 1998 0.86
47 Prognostic value of nucleoli and cell size in chronic lymphocytic leukemia. Am J Hematol 1978 0.86
48 Effects of tumor necrosis factor on PMN chemotaxis, chemiluminescence, and elastase activity. J Lab Clin Med 1989 0.85
49 Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial. Cancer J Sci Am 1999 0.85
50 Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study. Cancer 1990 0.84
51 Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation. J Allergy Clin Immunol 1986 0.84
52 Cell Biology Symposium: genetics of feed efficiency in dairy and beef cattle. J Anim Sci 2013 0.84
53 Evaluation of a proposed method for phenytoin maintenance dose prediction following an intravenous loading dose. Eur J Clin Pharmacol 1987 0.83
54 Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study. J Clin Oncol 1990 0.83
55 Prognostic value of serum lactic dehydrogenase level in Hodgkin's disease. J Lab Clin Med 1982 0.82
56 Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence. Am Rev Respir Dis 1990 0.82
57 Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipients. Transplantation 1985 0.82
58 Reducing GHG emissions through genetic improvement for feed efficiency: effects on economically important traits and enteric methane production. Animal 2013 0.82
59 A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group study. Invest New Drugs 1990 0.81
60 Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study. J Clin Oncol 1994 0.81
61 Kissing stents in the aortic bifurcation. Am Heart J 1998 0.80
62 Attenuation of LPS-induced neutrophil thromboxane b2 release and chemiluminescence. J Cell Physiol 1991 0.80
63 Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base. Cancer 1993 0.80
64 Estrogen use - risk of endometrial carcinoma. Gynecol Oncol 1978 0.80
65 The diversity and idiotypic patterns of human rheumatoid factors in disease. Concepts Immunopathol 1988 0.79
66 Toxicity of amphotericin B, miconazole, and ketoconazole to human granulocyte progenitor cells in vitro. Antimicrob Agents Chemother 1983 0.79
67 Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group. Clin Cancer Res 2001 0.79
68 Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Southwest Oncology Group. Ann Thorac Surg 1994 0.79
69 Theophylline clearance in patients with severe chronic obstructive pulmonary disease receiving supplemental oxygen and the effect of acute hypoxemia. Am Rev Respir Dis 1986 0.79
70 Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study. Cancer Chemother Pharmacol 1997 0.79
71 Accuracy of genomic predictions for feed efficiency traits of beef cattle using 50K and imputed HD genotypes. J Anim Sci 2016 0.78
72 Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study. J Clin Oncol 1995 0.78
73 Plasma dehydroepiandrosterone sulfate, androstenedione and cortisol, and urinary free cortisol excretion in breast cancer. Eur J Cancer 1977 0.78
74 Clinical significance of crepitations in elderly patients following acute hospital admission: a prospective study. Age Ageing 1992 0.78
75 Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: a Southwest Oncology Group study. Invest New Drugs 1995 0.78
76 Fatal liver disease associated with alpha 1-antitrypsin deficiency PiM1/PiMduarte. Gastroenterology 1987 0.78
77 Cellular sources of thymidine nucleotides: studies for PET. J Nucl Med 1987 0.78
78 An evaluation of anesthesiologists' present checkout methods and the validity of the FDA checklist. Anesthesiology 1991 0.78
79 Impaired beta-adrenoceptor function, increased leukocyte respiratory burst, and bronchial hyperresponsiveness. J Allergy Clin Immunol 1992 0.78
80 Summary of the proceedings of the United States--Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998. Lung Cancer 1999 0.77
81 Local drug delivery of argatroban from a polymeric-metallic composite stent reduces platelet deposition in a swine coronary model. Catheter Cardiovasc Interv 1999 0.77
82 Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH. J Eur Acad Dermatol Venereol 2013 0.76
83 Observational studies and randomized trials. N Engl J Med 2000 0.76
84 Minoxidil-associated pericarditis and fatal cardiac tamponade. West J Med 1985 0.76
85 Effects of erythromycin on the rabbit pleura: its potential role as a pleural sclerosant. Am J Respir Crit Care Med 1995 0.76
86 A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study. Invest New Drugs 1997 0.76
87 Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment. J Infect Dis 1984 0.76
88 Relationship between nonspecific bronchial responsiveness to methacholine and peripheral mononuclear leukocyte beta-adrenergic receptor function in young drug-naive subjects. Am Rev Respir Dis 1992 0.76
89 Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization. Genes Brain Behav 2013 0.76
90 Magnetic resonance imaging planes for the 3-dimensional characterisation of human coronary arteries. J Anat 1994 0.75
91 Peripheral mononuclear leucocyte beta adrenoceptors and non-specific bronchial responsiveness to methacholine in young and elderly normal subjects and asthmatic patients. Thorax 1994 0.75
92 Balloon mitral valvuloplasty: comparison of haemodynamic and echocardiographic assessment of mitral stenosis at different heart rates in the catheterisation laboratory. Int J Cardiol 1999 0.75
93 Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229). Int J Radiat Oncol Biol Phys 1998 0.75
94 Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group. Cancer 1996 0.75
95 Transoesophageal echocardiography--widening the scope. Ir Med J 1992 0.75
96 Vindesine. A phase II trial in advanced breast cancer patients. Cancer Clin Trials 1981 0.75
97 Clinical studies of a fast homoarginine-sensitive alkaline phosphatase in patients with cancer. Cancer Res 1981 0.75
98 Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma. A Southwest Oncology Group study. Invest New Drugs 1991 0.75
99 Local administration of L-703,081 using a composite polymeric stent reduces platelet deposition in canine coronary arteries. Am J Cardiol 1998 0.75
100 Creation of a semiannual report for a multicentre co-operative clinical trials group. Stat Med 1992 0.75
101 Prognostic signs in chronic myelocytic leukemia. Am J Hematol 1979 0.75
102 Cigarette smoking and theophylline metabolism: effects of phenytoin. Clin Pharmacol Ther 1987 0.75
103 Effects of radiation type and dose and the role of glucocorticoids, gonadectomy, and thyroidectomy in mammary tumor induction in mammotropin-secreting pituitary tumor-grafted rats. Cancer Res 1978 0.75
104 Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancer. Lung Cancer 2001 0.75
105 Phase II trial of piroxantrone in advanced non-small cell carcinoma of the lung. A Southwest Oncology Group study. Invest New Drugs 1992 0.75
106 Mitral balloon valvuloplasty in patients > 70 years of age with severe mitral stenosis. Am J Cardiol 1995 0.75
107 Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study. Cancer Chemother Pharmacol 1991 0.75
108 Genetic studies of four highly homologous rheumatoid factor-associated Vk genes in rheumatoid arthritis patients and normal individuals. Mol Immunol 1991 0.75
109 Idiotypes and the structural diversity of human rheumatoid factors. Springer Semin Immunopathol 1988 0.75
110 Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study. Cancer 1993 0.75
111 Interpretation of survival data in clinical trials. Oncology (Williston Park) 1991 0.75
112 Prognostic value of blood glucose in Hodgkin's disease. J Clin Oncol 1984 0.75
113 Aging and the response to inhibition and induction of theophylline metabolism. Exp Gerontol 1993 0.75
114 Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team. Semin Oncol 1997 0.75
115 Idiotypic characteristics of rheumatoid factors. Scand J Rheumatol Suppl 1988 0.75
116 A graphical approach to the analysis of censored data. Breast Cancer Res Treat 1992 0.75
117 Beta-adrenergic regulation of the eosinophil respiratory burst as detected by lucigenin-dependent luminescence. J Allergy Clin Immunol 1995 0.75